Project Grant R21AI193594
- Federal Project Grant Award Summary Tufts University School of Medicine received a $151,760 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 30, 2026, with completion targeted for April 29, 2029. The grant funds research investigating the regulation of amidase activity during bacterial spore development in Clostridioides difficile, a pathogenic organism critical to...
- Federal Project Grant Award Summary Tufts University School of Medicine received a $3.18M Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 26, 2025, with completion expected July 31, 2029. The award funds investigation of Yop effector protein activities in Microfold (M) cells during murine infection with Yersinia pseudotuberculosis (YPTB). The research utilizes a...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a $450,630 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a two-year project period from August 1, 2025, through July 31, 2027. The award funds spatiotemporal investigation of interactions between pneumolysin, pulmonary epithelium, and polymorphonuclear leucocytes (PMNs/neutrophils) that contribute to...
- Federal Grant Award Summary Tufts University School of Medicine received a $136,104 Project Grant award dated October 24, 2025, from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant funds investigator-initiated research examining how the spatial distribution and epithelial association of Clostridioides difficile bacteria, combined with heterogeneous toxin gene expression, influence disease...
- Federal Project Grant Award Summary Tufts University School of Medicine received a $453,750 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025 through July 31, 2027. The grant funds research to investigate mechanisms by which bacteriophages evade cyclic oligonucleotide-based antiviral defense systems in bacteria, with specific focus on how phage proteins antagonize...
- Federal Project Grant Award Summary Tufts University School of Medicine received a $647,187 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 3, 2025, with a completion date of June 30, 2030. The award supports biomedical research investigating the novel role of heme synthesis in controlling regulatory T cell (Treg) fitness and function. The research focuses on...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a $165,000 project grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 1, 2025, with a completion date of June 30, 2027. This award funds the development of an improved transposon mutagenesis system for comprehensive genetic analysis of Borrelia burgdorferi, the causative agent of Lyme disease. The primary deliverables...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a Project Grant of $243,600 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 23, 2026, with completion targeted for January 31, 2028. This award supports investigator-initiated biomedical research examining the role of CLCC1, an endoplasmic reticulum protein, in facilitating herpesvirus nuclear egress—the process...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a Project Grant totaling $859,278 (awarded February 19, 2026; completion date January 31, 2031) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to accelerate the discovery of narrow-spectrum antibiotics targeting Borrelia burgdorferi, the causative agent of Lyme disease. The primary deliverables include the development and refinement...
- Federal Grant Award Summary Tufts University School of Medicine received a $412,377 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 10, 2025, through August 31, 2028. The award supports research focused on developing and optimizing in vitro cultivation systems for long-term continuous propagation of Enterocytozoon bieneusi (EB), an intracellular spore-forming...
Tufts University School of Medicine received a $247,500 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 18, 2026 through April 30, 2028. The grant supports fundamental research into the transcriptional regulation mechanisms of AgrA, a key virulence factor in Listeria monocytogenes, a pathogenic bacterium affecting immunocompromised populations and pregnant women. The research will employ genome-wide molecular techniques, including in vitro DNA affinity purification coupled with sequencing and ChIP-seq (chromatin immunoprecipitation sequencing) experiments, to identify and characterize all genes directly regulated by AgrA with near-single-nucleotide resolution, thereby establishing the scientific foundation for understanding how this regulator controls virulence and biofilm development. The project delivers comprehensive genomic analysis products that will map AgrA-binding sites across the Listeria monocytogenes genome, rank their relative binding strengths, and define the conditions under which regulation occurs. These research outputs will enable future mechanistic studies into how AgrA individually regulates specific genes and coordinates bacterial pathogenesis. The research also examines the broader regulatory hierarchy by investigating how CodY, a global metabolic and virulence regulator, controls the AGR locus itself, thereby advancing understanding of multilayered transcriptional control systems in low G+C gram-positive bacterial pathogens.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $247.5k | 5/19/26 |